| Monash IVF Group Limited (MVF) ORDINARY FULLY PAID |
Health Care |
$275 |
MVF delivers 1H26 Underlying NPAT of $10.4m
|
26 Feb 2026 9:15AM |
$0.690 |
$0.705 |
risen by
2.17%
|
|
MVF - Price-sensitive ASX Announcement
Full Release
Key Points
- 1H26 revenue of $137.9 million, a 1.8% decrease from 1H25.
- Underlying NPAT for 1H26 was $10.4 million.
- Maintained leading clinical pregnancy rates and completed major infrastructure transformation.
- 1.2 cents per share FY26 fully franked interim dividend declared.
- Syndicated Debt Facility increased to $110 million.
- Net Debt increased to $96.2 million as of 31 December 2025.
- Capital expenditure of $10 million in 1H26.
- FY26 profit guidance for underlying NPAT of $20 million.
- CEO Dr. Victoria Atkinson emphasizes clinical and operational excellence.
- CFO recruitment process is underway.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nelson Resources Limited (NES) ORDINARY FULLY PAID |
Materials |
$10 |
Exploration Teams Mobilised to Gold Point
|
26 Feb 2026 9:15AM |
$0.005 |
$0.004 |
fallen by
30%
|
|
| Monash IVF Group Limited (MVF) ORDINARY FULLY PAID |
Health Care |
$275 |
1H26 Appendix 4D and Financial Report
|
26 Feb 2026 9:14AM |
$0.690 |
$0.705 |
risen by
2.17%
|
|
MVF - Price-sensitive ASX Announcement
Full Release
Key Points
- Underlying NPAT for 1H26 was $10.41 million, a 34.0% decrease from the previous period.
- Revenue declined by 1.8% to $137.86 million due to market share loss in the Australian IVF segment.
- International revenue increased by 14.3%, driven by growth in stimulated cycles.
- Reported NPAT was $7.545 million, a 56.4% decrease from the previous period.
- A fully franked interim dividend of 1.2 cents per share was declared.
- Financial results include adjustments for non-recurring items.
- Operational challenges included increased costs and market dynamics.
- Strategic focus remains on growth opportunities and operational efficiencies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Waypoint REIT Limited (WPR) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,574 |
Waypoint REIT Results Presentation FY25
|
26 Feb 2026 9:14AM |
$2.480 |
$2.410 |
fallen by
2.82%
|
|
| Waypoint REIT Limited (WPR) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,574 |
Waypoint REIT FY25 Results
|
26 Feb 2026 9:14AM |
$2.480 |
$2.410 |
fallen by
2.82%
|
|
| Waypoint REIT Limited (WPR) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,574 |
Update - Dividend/Distribution - WPR
|
26 Feb 2026 9:13AM |
$2.480 |
$2.410 |
fallen by
2.82%
|
|
| RAS Technology Holdings Limited (RTH) ORDINARY FULLY PAID |
Industrials |
$26 |
RTH Appendix 4D & 31 December 2025 Half-year report
|
26 Feb 2026 9:13AM |
$0.750 |
$0.550 |
fallen by
26.67%
|
|
RTH - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 38.3% to $13.933 million.
- Loss attributable to owners was $391,000.
- Significant investments in growth and strategic expansions.
- Focus on proprietary full racing solution and Managed Trading Service (MTS).
- No dividends declared for the period.
- Net tangible assets per share at 6.42 cents.
- Strategic expansion in Asia, notably Hong Kong.
- Emphasis on strengthening existing capabilities and partnerships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Westgold Resources Limited (WGX) ORDINARY FULLY PAID |
Materials |
$4,800 |
FY26 Half Year Results Presentation
|
26 Feb 2026 9:13AM |
$7.810 |
$5.080 |
fallen by
34.96%
|
|
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$8,501 |
Half Year Review to 31 December 2025
|
26 Feb 2026 9:13AM |
$6.930 |
$6.880 |
fallen by
0.72%
|
|
| Waypoint REIT Limited (WPR) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,574 |
Appendix 4E and Audited Financial Statements FY25
|
26 Feb 2026 9:13AM |
$2.480 |
$2.410 |
fallen by
2.82%
|
|
| Austin Engineering Limited (ANG) ORDINARY FULLY PAID |
Industrials |
$87 |
Austin Half Year 2026 Results & Guidance Update
|
26 Feb 2026 9:12AM |
$0.265 |
$0.140 |
fallen by
47.17%
|
|
ANG - Price-sensitive ASX Announcement
Full Release
Key Points
- Group revenue down to $170.3 million in FY26 H1.
- EBITDA decreased by 63% and EBIT by 83%.
- Net profit after tax was $2 million.
- Operating cash flow improved to $6.6 million.
- $51 million in new orders secured post-period.
- Chilean operations suffered a $4.1 million loss.
- Actions taken to improve operational efficiency in Chile, US, and Indonesia.
- Updated FY26 revenue guidance of $350+ million.
- Focus on restoring margins, cash generation, and operational execution.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Talius Group Limited (TAL) ORDINARY FULLY PAID |
Information Technology |
$27 |
Change of Director's Interest Notice - RC
|
26 Feb 2026 9:12AM |
$0.072 |
$0.079 |
risen by
9.72%
|
|
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$34 |
NHS England ColoSTAT Evaluation Commences
|
26 Feb 2026 9:11AM |
$0.225 |
$0.096 |
fallen by
57.33%
|
|
| SPC Global Holdings Ltd (SPG) ORDINARY FULLY PAID |
Consumer Staple |
$115 |
H1 FY26 Investor Presentation
|
26 Feb 2026 9:11AM |
$0.390 |
$0.096 |
fallen by
75.38%
|
|
SPG - Price-sensitive ASX Announcement
Full Release
Key Points
- Net sales revenue of $171.5M and EBITDA of $13.0M reported for H1 FY26.
- Domestic division focused on profit growth through portfolio optimization and productivity improvements.
- International division faced timing challenges with major sales events but aimed for improved margins.
- Strategic initiatives include inventory management, strategic partnerships, and international expansion.
- Focus on leveraging scalable growth platforms and enhancing earnings quality.
- Pursuing synergies of over $16M across FY26 and FY27.
- Ongoing transition to platform-led acceleration in the domestic market.
- Strategic shift in international division towards high-margin, specialized products.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Austral Resources Australia Ltd (AR1) ORDINARY FULLY PAID |
Materials |
$177 |
Letter to Eligible SPP Shareholders - Offer Opens
|
26 Feb 2026 9:11AM |
$0.091 |
$0.071 |
fallen by
21.98%
|
|
AR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Austral Resources Australia Ltd (AR1) is offering various share placement opportunities detailed in the prospectus.
- The prospectus outlines a Shareholder Priority Placement (SPP) for eligible shareholders to purchase shares at $0.09 each.
- The SPP aims to raise up to $5 million and is exclusively available to eligible shareholders in Australia and New Zealand.
- The prospectus includes the Placement Offer, QCMBTF Offer, AES Offer, and the SPP collectively referred to as the Offers.
- The Placement Offer involves issuing 130,853,456 new shares to raise approximately $11.78 million.
- The QCMBTF Offer involves issuing 166,666,667 new shares under the terms of a Share Subscription Agreement.
- The AES Offer includes issuing up to 40 million new shares in exchange for the AES Debt.
- All offers are subject to shareholder approval and other specified conditions.
- The document provides key dates, including the opening and closing dates for the respective offers.
- Participation in the SPP is non-renounceable and cannot be transferred.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pacific Current Group Limited (PAC) ORDINARY FULLY PAID |
Financials |
$329 |
Update - Notification of buy-back - PAC
|
26 Feb 2026 9:11AM |
$10.040 |
$11.750 |
risen by
17.03%
|
|
| SPC Global Holdings Ltd (SPG) ORDINARY FULLY PAID |
Consumer Staple |
$115 |
H1 FY26 Financial Results & Strategic Update
|
26 Feb 2026 9:10AM |
$0.390 |
$0.096 |
fallen by
75.38%
|
|
SPG - Price-sensitive ASX Announcement
Full Release
Key Points
- SPC Global Holdings Ltd reported a Group Net Sales Revenue (NSR) of $171.5 million for H1 FY26.
- The Group achieved a normalised EBITDA of $13.0 million in H1 FY26.
- Domestic business delivered an NSR of $155.6 million with significant margin improvement.
- International business faced a decrease in NSR to $15.9 million due to timing of sales events and a contract transition.
- Sales contribution margin in the International business increased to 50.3%.
- The Group achieved $16 million in synergy benefits in H1 FY26.
- SPC Global's synergy program in FY26 realised $2 million in SG&A efficiencies and $3.5 million from procurement.
- The Group is on track to deliver a 25% year-over-year increase in normalised EBITDA for FY26.
- SPC Global continues to expand internationally, focusing on high-margin products.
- The Group plans to close the Mill Park site by August 2026 as part of its integration and synergy efforts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$53 |
Neurizon Initiates Dosing in HEALEY ALS Platform Trial
|
26 Feb 2026 9:10AM |
$0.096 |
$0.070 |
fallen by
27.08%
|
|
NUZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Neurizon initiates dosing of NUZ-001 in HEALEY ALS Platform Trial.
- Trial is a Phase 2/3 study enrolling approximately 160 participants with ALS.
- NUZ-001 was previously evaluated in a successful Phase 1 study.
- The trial is conducted across over 70 sites in the US.
- The HEALEY ALS Platform Trial aims to accelerate ALS therapy development.
- The trial employs a multicentre, double-blind, placebo-controlled design.
- The study will complete enrolment in the second half of 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nagambie Resources Limited (NAG) ORDINARY FULLY PAID |
Materials |
$11 |
Trading Halt
|
26 Feb 2026 9:10AM |
$0.016 |
$0.009 |
fallen by
43.75%
|
|
NAG - Price-sensitive ASX Announcement
Full Release
Key Points
- Nagambie Resources Limited requested a trading halt on 26 February 2026.
- The halt is pending an announcement regarding capital raising.
- Trading will resume either on 2 March 2026 or upon market announcement.
- No reasons were identified by the company that could prevent the halt.
- No additional information necessary was identified by the company.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pureprofile Ltd (PPL) ORDINARY FULLY PAID |
Information Technology |
$36 |
H1 FY26 Results Presentation
|
26 Feb 2026 9:10AM |
$0.043 |
$0.030 |
fallen by
30.23%
|
|
PPL - Price-sensitive ASX Announcement
Full Release
Key Points
- Record H1 FY26 revenue of $33.3m, up 14% on pcp.
- Platform revenue grew 54%, supporting scalability.
- ROW revenue surpassed ANZ, reflecting geographic diversification.
- Net profit after tax increased 22% to $1.9m.
- Closing cash balance strengthened to $5.9m.
- Focused on innovative client solutions and AI integration.
- CRNRSTONE acquisition expected to be EPS accretive.
- Continued investment in platform capability and technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alligator Energy Limited (AGE) ORDINARY FULLY PAID |
Energy |
$231 |
Half Year Financial Report
|
26 Feb 2026 9:09AM |
$0.048 |
$0.052 |
risen by
8.33%
|
|
| Trek Metals Limited (TKM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$91 |
Trek Expands Kimberley-Tanami Manganese Position
|
26 Feb 2026 9:09AM |
$0.190 |
$0.125 |
fallen by
34.21%
|
|
| SPC Global Holdings Ltd (SPG) ORDINARY FULLY PAID |
Consumer Staple |
$115 |
Interim Financial Report H1 FY26
|
26 Feb 2026 9:09AM |
$0.390 |
$0.096 |
fallen by
75.38%
|
|
SPG - Price-sensitive ASX Announcement
Full Release
Key Points
- Gross revenue increased by 29.5% to $200.6 million.
- Net loss after tax improved to $19.6 million from $39.8 million.
- Normalised EBITDA rose to $13.0 million from $1.1 million.
- No dividends were paid or declared.
- Revenue growth primarily in Australia and New Zealand.
- No significant events affecting future operations were reported post-period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lynas Rare Earths Limited (LYC) ORDINARY FULLY PAID |
Materials |
$18,338 |
Lynas Rare Earths FY26 Half Year Presentation
|
26 Feb 2026 9:08AM |
$17.030 |
$18.220 |
risen by
6.99%
|
|
LYC - Price-sensitive ASX Announcement
Full Release
Key Points
- Mt Weld expansion largely commissioned, new flotation circuit operating at 70% capacity.
- Kalgoorlie Processing Facility ramp-up continued with process modifications.
- Record NdPr production achieved; significant increase in sales revenue.
- 65MW Mt Weld Hybrid Power Station fully operational, enhancing sustainability.
- U.S. market engagement includes government negotiations and awareness campaigns.
- Towards 2030 strategy focuses on performance optimization, capacity increase, and supply chain expansion.
- CEO Amanda Lacaze to retire at the end of the financial year; search for new CEO initiated.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lynas Rare Earths Limited (LYC) ORDINARY FULLY PAID |
Materials |
$18,338 |
Lynas Rare Earths FY26 Half Year Results
|
26 Feb 2026 9:08AM |
$17.030 |
$18.220 |
risen by
6.99%
|
|
LYC - Price-sensitive ASX Announcement
Full Release
Key Points
- Lynas Rare Earths Limited reported a significant increase in Net Profit After Tax (NPAT) to $80.2 million for the half year ending 31 December 2025.
- Revenue increased to $413.7 million from $254.3 million in the prior corresponding period.
- Total Rare Earth Oxide (REO) production increased to 6,375 tonnes from 5,339 tonnes.
- Sales volume rose to 6,050 tonnes from 5,708 tonnes.
- Average selling price increased to $68.4 per kilogram.
- Lynas completed commissioning of the Mt Weld expansion project.
- The company launched its 'Towards 2030' growth strategy and completed an equity raising to support this initiative.
- Lynas is the only commercial producer of separated Light and Heavy Rare Earth oxides outside China.
- Operational highlights included major maintenance and the expansion of the Heavy Rare Earth separation facility in Malaysia.
- Memorandum of Understanding signed with a permanent magnet manufacturer to enhance the supply chain outside China.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
